Reviewing fair subject selection considerations for the unique case of post sequelae COVID-19 translational studies
Fair inclusion of research subjects is necessary to ensure that post-acute sequelae COVID-19 (PASC) research results benefit all members of society. Scientists should conduct research on a broad sample of individuals who represent clinically relevant factors influencing a disease. Without demographi...
Main Authors: | E.M. Smith, E.E. Anderson, R. Deer, J. Prochaska, K. Bohn, S. Croisant |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-01-01
|
Series: | Journal of Clinical and Translational Science |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866122004253/type/journal_article |
Similar Items
-
Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach
by: Rieke van der Graaf, et al.
Published: (2018-01-01) -
The elusive ideal of inclusiveness: lessons from a worldwide survey of neurologists on the ethical issues raised by whole-genome sequencing
by: Thierry Hurlimann, et al.
Published: (2017-04-01) -
Fair Data: History and Present Context
by: Ana Carballo-Garcia, et al.
Published: (2022-12-01) -
Challenges of the prosecutor in the implementation of a fair trial and its solutions
by: Rahman peyvast, et al.
Published: (2022-09-01) -
FAIR Begins at home: Implementing FAIR via the Community Data Driven Insights
by: Carlos Utrilla Guerrero, et al.
Published: (2022-10-01)